Delivery Order SPE2DR25D1100-SPE2DR26FCV6S
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Voranigo 40 mg tablets (30-count packages) under a firm fixed-price contract with a ceiling value of $57,107.82 and an ultimate completion date of January 12, 2026. This non-set-aside, competitively awarded delivery order represents a specific pharmaceutical fulfillment requirement within the federal medical supply chain. The award was issued to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $28,553.91 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on December 15, 2025, with completion expected by January 7, 2026. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a $28,553.91 delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed price contract. The order, issued on December 18, 2025, with an ultimate completion date of January 12, 2026, represents a non-set-aside, competitively awarded procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This...
- The Defense Logistics Agency awarded a $28,553.91 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on December 16, 2025, with an ultimate completion date of January 8, 2026. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $51,556.64 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed price contract. The award was made on December 17, 2025, with an ultimate completion date of January 9, 2026, and represents a non-competitive, non-set-aside procurement. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a $27,094.95 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Voranigo 40 mg tablets (30-count units). This firm fixed-price contract, designated as a non-competitive, non-set-aside award, is scheduled for completion by November 28, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a delivery order valued at $26,231.49 to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) under a firm fixed-price contract. The award was issued on November 12, 2025, with an ultimate completion date of December 4, 2025, and utilizes no set-aside designation, indicating competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $78,694.47 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count units) on December 2, 2025, with completion scheduled for December 23, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered...
- The Defense Logistics Agency awarded a $52,462.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Voranigo 40 mg tablets (30-count units) on November 24, 2025, with completion scheduled for December 16, 2025. This is a non-set-aside, competitively awarded contract with performance at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this order as a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) under a firm fixed-price contract with a ceiling value of $54,189.90. The contract, which became effective on May 2, 2025, with an ultimate completion date of May 23, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania,...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCV6SDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Voranigo 40 mg tablets (30-count packages) under a firm fixed-price contract valued at $57,107.82. The award, issued on December 18, 2025, with an ultimate completion date of January 12, 2026, represents a non-competitive delivery order without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location and is fulfilling this order as a child contract under its larger vehicle with DLA. This delivery order is executed under AmerisourceBergen Drug Corp's comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's significant contract portfolio with DLA demonstrates its capability to fulfill federal medical procurement requirements across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and related medical supplies serving the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $57.1k | 12/17/25 |